Frontal burr hole approach for neuroendoscopic resection of craniopharyngioma with the NICO Myriad device: report of two cases

Moore, Reilin J.; Scherer, Andrea; Fulkerson, Daniel H.

doi:10.1007/s00381-017-3386-1

Cited by 7 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We found 17 reports that utilized the NTVA (with and without Ommaya reservoir insertion) for the treatment of CC in 67 patients, with a follow-up period ranging from six to 73 months; the recurrence rate ranged between nil to 54% (Table 1) [2][3][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]. The surgical modality of choice may differ depending on patient-and/or tumor-related factors.…”

Section: Discussionmentioning

confidence: 99%

Neuroendoscopic Transventricular Approach for Cystic Craniopharyngioma

Noureldine

Khodmehr

Sabahi

et al. 2021

Cureus

View full text Add to dashboard Cite

The literature is rich with many studies reporting different treatment modalities and approaches for cystic craniopharyngioma (CC), including microsurgery, neuroendoscopic transventricular approach, endoscopic transnasal surgery, stereotactic drainage, and Ommaya reservoir insertion. The goals of this manuscript are to report the successful treatment of an atypical case of CC using the neuroendoscopic transventricular approach (NTVA) as well as discuss the different surgical modalities for these tumors following a comprehensive review of the literature. Our patient is a nine-year-old female with a large CC who was managed using the NTVA. No complications or recurrence occurred over two years of follow-up. Results of our literature review showed lower recurrence and complication rates of the NTVA compared to other surgical modalities. The NTVA is potentially efficient, reliable, and safe for managing CC and cysticdominant craniopharyngiomas, with low recurrence and complication rates compared to microsurgery and Ommaya reservoir insertion. Future randomized clinical studies comparing the various treatment modalities of CC are needed to solidify these conclusions.

show abstract

Section: Discussionmentioning

confidence: 99%

Neuroendoscopic Transventricular Approach for Cystic Craniopharyngioma

Noureldine

Khodmehr

Sabahi

et al. 2021

Cureus

View full text Add to dashboard Cite

show abstract

“…Transventricular trans-endoscopic approach was minimally invasive, safe and effective in this selected case. This approach for giant cystic craniopharyngiomas has already been described in a few cases, alone or in combination with further microsurgical removal [12][13][14][15][16][17] . In our case, it allowed not only decompression through creation of a wide communication between liquor spaces, but also a near-total resection of the lesion.…”

Section: Discussionmentioning

confidence: 99%

Trans-Endoscopic Treatment of Craniopharyngioma and Recovery from Blindness in Adult Patient – a Case Report

Jugović

Spazzapan

Porčnik

et al. 2020

ACC

View full text Add to dashboard Cite

We report a case of trans-endoscopic transventricular approach to a large cystic craniopharyngioma. Surgery was performed three days after visual acuity on both eyes deteriorated to blindness. Magnetic resonance imaging before surgery revealed a large lesion in the suprasellar region that severely compressed the optic chiasm and displaced the third ventricle upward. The lesion was operated through the trans-endoscopic transventricular approach, with the aim of urgent decompression of the optic apparatus. At first, wide ventriculo-cysto-cisternostomy was performed, and then tumor tissue was removed. Postoperatively, visual acuity significantly improved on one eye. Our case shows that this minimally invasive technique is safe and effective and can be an alternative treatment for large cystic craniopharyngiomas. The reported case also shows that loss of vision can still be recovered even after the 72-hour period in adults.

show abstract

“…One application of cyst fenestration that has been utilized with increasing frequency is transventricular endoscopic wide fenestration 151,[157][158][159] . This approach is effective for the control of monocystic disease in which the cyst extends into or fills the third ventricle, and results in obstructive hydrocephalus.…”

Section: Cyst Fenestrationmentioning

confidence: 99%

“…This aids in decision-making regarding further care 55 . GTR has been achieved through a trans-ventricular endoscopic approach 158 , although in most cases this is not the goal.…”

Section: Cyst Fenestrationmentioning

confidence: 99%

Contemporary Biological Insights and Clinical Management of Craniopharyngioma

et al. 2022

View full text Add to dashboard Cite

Craniopharyngiomas are clinically aggressive tumours due to their invasive behaviour and recalcitrant tendency to recur after therapy. There are two types based on their distinct histology and molecular features: The papillary craniopharyngioma (PCP), which is associated with BRAF-V600E mutations and the adamantinomatous craniopharyngioma (ACP), characterised by mutations in CTNNB1 (encoding β-catenin). Patients with craniopharyngioma show symptoms linked to the location of the tumour close to the optic pathways, hypothalamus and pituitary gland, such as increased intracranial pressure, endocrine deficiencies and visual defects. Treatment is not specific and mostly non-curative, and frequently includes surgery, which may achieve gross-total or partial resection, followed by radiotherapy. In cystic tumours, frequent drainage is often required and intracystic instillation of drugs has been used to help manage cyst refilling. More recently targeted therapies have been used, particularly in papillary craniopharyngioma, but also now in adamantinomatous craniopharyngioma and clinical trials are underway or in development. Although patient survival is high, the consequences of the tumour and its treatment can lead to severe comorbidities resulting in poor quality of life, in particular for those patients that bear tumours with hypothalamic involvement. Accordingly, in these patients at risk for the development of a hypothalamic syndrome hypothalamus-sparing treatment strategies such as limited resection followed by irradiation are recommended. In this review, we provide an update on various aspects of craniopharyngioma, with emphasis on recent advances in the understanding of tumour pathogenesis, clinical consequences, management and therapies.

show abstract

Frontal burr hole approach for neuroendoscopic resection of craniopharyngioma with the NICO Myriad device: report of two cases

Cited by 7 publications

References 24 publications

Neuroendoscopic Transventricular Approach for Cystic Craniopharyngioma

Neuroendoscopic Transventricular Approach for Cystic Craniopharyngioma

Trans-Endoscopic Treatment of Craniopharyngioma and Recovery from Blindness in Adult Patient – a Case Report

Contemporary Biological Insights and Clinical Management of Craniopharyngioma

Contact Info

Product

Resources

About